Atrial Fibrillation, Atrial Fibrillation Paroxysmal
Conditions
Brief summary
Atrial fibrillation (AF) is a serious public health problem because of its increasing incidence and prevalence in the aging population. ECG is the most commonly used gold standard for clinical diagnosis of arrhythmias, but conventional ECG examinations are not adequate for long-term ECG follow-up measurements in patients with AF. In this study, the AF patients will wear an watch and ECG patch to continuously monitor ECG and PPG. The software uses an integrated diagnostic mechanism of AF burden + AF segments to efficiently analyze ECG and PPG data, which can quickly and accurately identify the occurrence of AF and analyze AF burden in real-time, facilitating physicians' diagnosis and treatment and efficacy assessment.
Detailed description
PPG-AF study is a Cohort randomized observational study.The trial will include patients with AF who meet the study requirements from Beijing Anzhen Hospital within 2 months. Each participant will wear an watch and ECG monitor after admission to hospital until Radiofrequency ablation for AF, and after AF ablation until discharge. And more than 18 hours in each period. 1. Primary endpoint. The ECG and PPG data are automatically analyzed by the AF analysis software. The results are compared with expert-annotated gold standard results to verify the sensitivity and specificity. 2. Secondary endpoints. The AF burden calculated from PPG data is compared with that from ECG monitoring, to verify the feasibility of daily monitoring of AF burden using PPG analysis.
Interventions
DEVICEECG/PPG monitoring
The enrolled patients will wear an ECG patch and watch at the same time to collect ECG and PPG data respectively. The data collection time is from the day of hospitalization to before the ablation operation, and from 2 hours after the removal of ECG monitoring equipment to before leaving the hospital. The monitoring duration of each patient shall not be less than 18 hours.
Sponsors
Heart Health Research Center
Beijing Anzhen Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
* Be at least 18 years of age. * Have clear ECG-recorded atrial fibrillation in the past and will undergo atrial fibrillation ablation in the current hospitalization. * Patients who agree to wear both the watch and the ECG recorder.
Exclusion criteria
* Inability to wear the watch due to limited mobility or other problems. * Severe skin diseases such as skin allergies or skin ulcers. * Chronic insomnia not treated with medication. * Patients with severe cardiovascular disease who may be resuscitated at any time. * Previous history of Parkinson's, schizophrenia, epilepsy. * Black people and those with excessively dark skin.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The ECG and PPG data are automatically analyzed by the AF analysis software. | Two months after enrollment of the first subject | The results are compared with expert-annotated gold standard results to verify the sensitivity and specificity. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The AF burden calculated from PPG data is compared with that from ECG monitoring. | Two months after enrollment of the first subject | The AF burden calculated from PPG data is compared with that from ECG monitoring, to verify the feasibility of daily monitoring of AF burden using PPG analysis. |
Countries
China
Contacts
Primary ContactChang Sh Ma, Dr.
Outcome results
None listed